Michelle L. Mellion's most recent trade in PepGen Inc was a trade of 7,571 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 7,571 | 50,000 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 7,571 | 0 | - | 18.1 | 136,741 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 7,571 | 7,571 | - | 10.2 | 77,300 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 201 | 201 | - | 10.2 | 2,052 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 201 | 57,571 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jul 2024 | 201 | 0 | - | 18.0 | 3,619 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 18 Jul 2024 | 12,625 | 12,625 | - | 10.2 | 128,901 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 18 Jul 2024 | 12,625 | 57,772 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 18 Jul 2024 | 12,625 | 0 | - | 18.2 | 229,804 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 5,901 | 70,397 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 5,901 | 0 | - | 18.0 | 106,247 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 5,901 | 5,901 | - | 10.2 | 60,249 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 3,288 | 3,288 | - | 10.2 | 33,570 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 3,288 | 76,298 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 12 Jul 2024 | 3,288 | 0 | - | 18.0 | 59,331 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 875 | 0 | - | 18.0 | 15,760 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 875 | 875 | - | 10.2 | 8,934 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 875 | 79,623 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 37 | 37 | - | 10.2 | 378 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 37 | 79,586 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 01 Jul 2024 | 37 | 0 | - | 18.1 | 669 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jun 2024 | 9,260 | 80,498 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jun 2024 | 9,260 | 0 | - | 18.2 | 168,427 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 24 Jun 2024 | 9,260 | 9,260 | - | 10.2 | 94,545 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 1,086 | 89,758 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 1,086 | 0 | - | 18.1 | 19,615 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 1,086 | 1,086 | - | 10.2 | 11,088 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 500 | 90,844 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 500 | 500 | - | 10.2 | 5,105 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | Chief Medical Officer | 11 Jun 2024 | 500 | 0 | - | 18.0 | 9,022 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 7,245 | 7,245 | - | 10.2 | 73,971 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 7,245 | 0 | - | 18.1 | 131,062 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 7,245 | 92,755 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 1,411 | 91,344 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 1,411 | 1,411 | - | 10.2 | 14,406 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 05 Jun 2024 | 1,411 | 0 | - | 18 | 25,398 | Common Stock | |
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 01 Mar 2024 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 01 Mar 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | SVP, Clinical Development | 01 Mar 2023 | 20,000 | 95,000 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | See Remarks | 01 Jul 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| PepGen Inc | Michelle L. Mellion | See Remarks | 06 May 2022 | 16,655 | 16,655 | - | - | Stock Option (Right to Buy) |